EPISODE · Mar 24, 2026 · 6 MIN
The €1.7 trillion PFAS question: treat or ban?
from BlueNotes · host BlueTech Research®
PFAS regulation in Europe is forcing a fundamental question: treat the problem — or eliminate it at source? In this episode, Research Analyst Dr. Bilal Asif unpacks new EU cost data showing how treatment-heavy approaches can drive costs into the trillions, while upstream bans significantly reduce long-term burden. The implications for utilities, industry and policymakers are substantial.This Analyst Spotlight is part of BlueTech's Weekly Analyst Insights membership.If you’d like to receive these signals from the water technology market each week, you can learn more about on bluetechresearch.com.--Presented by BlueTech Research®, Actionable Water Technology Market Intelligence. Watch the trailer of Our Blue World: A Water Odyssey. Get involved, and learn more on the website: braveblue.world
Embed this episode
What this episode covers
PFAS regulation in Europe is forcing a fundamental question: treat the problem — or eliminate it at source? In this episode, Research Analyst Dr. Bilal Asif unpacks new EU cost data showing how treatment-heavy approaches can drive costs into the trillions, while upstream bans significantly reduce long-term burden. The implications for utilities, industry and policymakers are substantial. This Analyst Spotlight is part of BlueTech's Weekly Analyst Insights membership. If you’d like to receive ...
Ready to play
The €1.7 trillion PFAS question: treat or ban?
No transcript for this episode yet
Similar Episodes
No similar episodes found.